Deutsche Bank’s Phio Pharmaceuticals PHIO Stock Holding History

Deutsche Bank’s Portfolio PHIO Stock Details PHIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1	Closed	-$3K	–	5459
2019 Q1	$3K	Buy	+1	New	+$2.24K	﹤0.01%	5061
2018 Q1	–	Hold	0	–	–	–	5548
2017 Q4	–	Hold	0	–	–	–	5096
2017 Q3	–	Hold	0	–	–	–	5030
2017 Q2	–	Hold	0	–	–	–	5066
2017 Q1	–	Hold	0	–	–	–	5059
2016 Q4	–	Hold	0	–	–	–	5037
2016 Q3	–	Hold	0	–	–	–	5131
2016 Q2	–	Hold	0	–	–	–	5304
2015 Q1	–	Hold	0	–	-$8K	–	5737
2014 Q4	–	Hold	0	–	–	–	5770

Other funds holding PHIO

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KFS

Kelly Financial Services Braintree, Massachusetts $467M AUM 21.13% 1-Year Est. Return

Deutsche Bank's PHIO Position: Q2 2019 in Review

Deutsche Bank sold out of Phio Pharmaceuticals (PHIO) in Q2 2019, closing a stake of 1 share — an estimated $3K sold.

Deutsche Bank first reported a position in PHIO in Q1 2019 and held it in 1 quarter. The position peaked at $3K in Q1 2019. 9 funds tracked by Wall St. Rank hold PHIO as of Q2 2019.

Deutsche Bank reported no remaining Phio Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Deutsche Bank sold 1 Phio Pharmaceuticals share in Q2 2019, an estimated $3K.
Deutsche Bank first reported a position in Phio Pharmaceuticals in Q1 2019 and held it in 1 quarter.
Deutsche Bank's Phio Pharmaceuticals position peaked at $3K in Q1 2019.
9 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2019.

Based on Deutsche Bank's 13F filing for Q2 2019, filed 14 Aug 2019.